Enlivex Therapeutics
ENLV
ENLV
18 hedge funds and large institutions have $1.41M invested in Enlivex Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 6 closing their positions.
Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
4
Closed
6
Calls
$2.41M
Puts
$552K
Net Calls
+$1.85M
Net Calls Change
+$1.52M
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$168K |
| 2 |
2
Goldman Sachs
New York
|
$88K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$136K |
| 4 |
4
Morgan Stanley
New York
|
$189K |
| 5 |
5
Wells Fargo
San Francisco,
California
|
$77K |
